# Corporate Inversion Excise Tax — Expatriated Entities (§ 4985)

A corporate inversion occurs when a U.S. corporation restructures to place a foreign parent company on top of its corporate structure — technically reincorporating abroad while maintaining its U.S. bu

- Canonical: https://policyrisk.com/wiki/expatriated-entities-inversion-excise
- As of: 2026-11-01
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Domain: taxes
- Category: Excise Taxes
- Page type: topic
- U.S. Code anchor: none
- Last verified: not recorded

## Article

A **corporate inversion** occurs when a U.S. corporation restructures to place a foreign parent company on top of its corporate structure — technically reincorporating abroad while maintaining its U.S. business operations — primarily to reduce U.S. tax liability. Congress responded with a two-pronged approach: **§ 7874** limits the tax benefits of inversions (treating the foreign parent as a U.S. corporation if the former shareholders own too much of the new foreign entity), and **§ 4985** imposes a **15% excise tax** on the value of stock-based compensation received by "disqualified individuals" (insiders — executives, directors, and certain highly compensated employees) of an "expatriated corporation" during the inversion period. The § 4985 excise operates separately from the § 7874 anti-inversion rules and is designed to ensure insiders don't benefit from tax-free capital gains on their stock compensation when their company inverts. For the related excise on excess executive compensation in change-of-control transactions, see [golden parachute excise tax (§ 280G)](golden-parachute-280g.md). For how TCJA's GILTI and FDII regimes changed the economics of inversions, see [international tax — GILTI and FDII](international-tax-gilti-fdii.md).

## Current Law (2026)

| Parameter | Value |
|-----------|-------|
| Excise tax rate | 15% of the value of specified stock compensation |
| Who pays | The individual (disqualified individual), not the corporation |
| Who is a "disqualified individual" | Officers, directors, and employees compensated above the top 0.1% threshold of company employees |
| What is "specified stock compensation" | Options, restricted stock, deferred compensation, and similar interests in the expatriating corporation that vest or are paid during the inversion period |
| Inversion period | The 12 months before and after the inversion date |
| Triggering event | The corporation becomes an "expatriated entity" under § 7874 |
| § 7874 threshold | Foreign parent owns 60%+ of stock by value after the acquisition (full inversion treatment at 80%+) |
| Treaty override | No — the excise applies regardless of tax treaty benefits |

## Legal Authority

- **26 U.S.C. § 4985(a)** — Imposes the 15% excise tax: any disqualified individual of an expatriated corporation who receives specified stock compensation in connection with the inversion must pay 15% excise tax on the value of that compensation; the tax is imposed on the individual, not the corporation
- **26 U.S.C. § 4985(b)** — Liability for tax: the corporation is jointly and severally liable for the tax if it fails to deduct and withhold the 15% from the individual's compensation; creates a practical obligation for the corporation to collect the tax at payment
- **26 U.S.C. § 4985(c)** — Definitions: "disqualified individual" means any individual who is an officer, director, or beneficial owner of more than 1% of any class of stock of the corporation, or who is a highly compensated employee; "specified stock compensation" includes stock options, restricted stock, restricted stock units, phantom stock, stock appreciation rights, and substantially similar instruments
- **26 U.S.C. § 4985(d)** — Special rules: the tax applies to compensation held during the 12-month period beginning 6 months before the inversion date; compensation that is forfeited before the inversion completes does not trigger the excise
- **26 U.S.C. § 7874** — The companion anti-inversion statute: if a foreign corporation acquires substantially all the properties of a U.S. corporation and former shareholders own 80%+ of the foreign acquiring corporation, the foreign corporation is treated as a U.S. corporation for all U.S. tax purposes (full inversion block); at 60–79% ownership, certain tax benefits are denied

## How It Works

Before the 2004 American Jobs Creation Act and subsequent Treasury regulations, U.S. multinationals could dramatically reduce their global tax burden by reincorporating in a low-tax jurisdiction — Ireland, the Cayman Islands, Bermuda — while keeping their U.S. operations unchanged. Pfizer, Medtronic, and dozens of others executed or attempted inversions. **§ 7874** targets the corporate structure: if the former U.S. shareholders own 60–79% of the foreign acquiring entity, it becomes a "surrogate foreign corporation" — certain U.S. tax benefits are denied. If they own 80%+, the foreign corporation is fully treated as a U.S. domestic corporation — the inversion fails from a tax perspective entirely. The **§ 4985 excise** addresses insider compensation: when a U.S. corporation completes an inversion qualifying as an "expatriation" under § 7874, executives, directors, and major shareholders who hold stock options, restricted stock, or deferred compensation during the 12-month window centered on the inversion date owe a 15% excise tax on that compensation regardless of whether it has vested or been exercised. The corporation must withhold the tax; failure to withhold creates joint and several liability.

Post-2016 Treasury regulations (T.D. 9761) tightened the § 7874 rules by disregarding certain "built-in" assets when measuring ownership percentages — making it harder to structure a transaction that achieves the 60% threshold that would at least yield surrogate foreign corporation treatment. The practical power of these regulations was demonstrated dramatically in April 2016, when Treasury issued emergency anti-inversion guidance and Pfizer and Allergan — hours later — called off their planned $160 billion merger, one of the largest corporate deals in history. The episode illustrated how § 4985 and § 7874 work together with Treasury's regulatory authority to deter inversions through a combination of structural failure (the 80% rule), benefit denial (the 60–79% zone), and executive-compensation tax costs that make the transaction economics unappealing even when the corporate restructuring itself can be completed.

## How It Affects You

**If you're a corporate executive at a company considering or executing an inversion**: The § 4985 excise creates a direct, personal tax liability — **15% on the full value of all specified stock compensation** you hold during the 12-month inversion window (the 6 months before and 6 months after the inversion date), including unvested RSUs, unexercised stock options, phantom stock, stock appreciation rights, and deferred compensation tied to company equity. This tax is imposed on **you personally**, not on the company — though the company is required to withhold it and becomes jointly and severally liable if it doesn't. The math can be severe on large equity positions: a **$10 million unvested RSU portfolio** triggers **$1.5 million in excise tax** before you've received a dollar of the underlying compensation. Unlike the § 280G golden parachute excise (triggered by change in control), § 4985 fires at the reincorporation event itself — not on acceleration or payout. The corporation cannot gross you up for this tax on a deductible basis (§ 275 prohibits the deduction). Model your § 4985 exposure with M&A counsel and your personal tax advisor **before the deal closes** — post-closing, the analysis is academic.

**If you're a corporate attorney or M&A professional structuring a cross-border deal**: The § 4985 analysis is one piece of a multi-statute anti-inversion review. The threshold question is § 7874: if former U.S. shareholders will own **80%+ of the acquiring foreign corporation** after the deal, the foreign corporation is treated as a U.S. corporation for all U.S. tax purposes — the inversion fails entirely. At **60–79%** ownership, the transaction becomes a "surrogate foreign corporation" arrangement: certain U.S. tax attributes are stripped, but full domestic treatment is avoided. The 2016 Treasury regulations (T.D. 9761, finalized 2020) tightened the ownership calculation by disregarding **"cash box" assets** (foreign cash pools used to inflate the non-U.S. shareholder percentage) and stepping through transaction sequences — so pro forma ownership calculations must be run under the current regs, not pre-2016 assumptions. For deals near the 60% or 80% thresholds, the § 4985 exposure and § 7874 risk interact: a deal that clears the 80% test still triggers § 4985 for insiders if it crosses 60%. Also analyze the **§ 280G interaction** — change-in-control payments in connection with the inversion may be "parachute payments" triggering a parallel 20% excise analysis for the same executive compensation package.

**If you're a shareholder in a U.S. company evaluating a cross-border merger**: Post-TCJA and post-§ 7874, **full corporate inversions offer essentially no remaining U.S. tax benefit for most companies** — and come with real costs. § 4985 taxes insiders, § 7874 may eliminate the foreign tax benefit entirely, GILTI imposes a minimum tax on foreign income regardless of jurisdiction, and reputational and Congressional scrutiny can follow. The deals that defined the 2014–2016 inversion wave — Medtronic-Covidien, AbbVie-Shire, Pfizer-Allergan's $160 billion cancelled deal — have not been replicated at scale. What has replaced inversions for international tax efficiency: legitimate IP migration to Ireland, Singapore, or the Netherlands (governed by transfer pricing arm's-length standards), **FDII** deductions for U.S.-based IP serving foreign markets, and TCJA's **21% corporate rate** (which narrowed the U.S.-to-offshore differential). For shareholders evaluating M&A scenarios, if a deal involves a cross-border merger, check the acquirer's **Form S-4 or proxy statement** — filed with the SEC at **sec.gov/edgar** — for required disclosure of § 7874 analysis and any material U.S. tax consequences of the transaction structure.

**If you're a tax researcher, policy analyst, or Treasury/IRS practitioner tracking anti-inversion law**: The § 4985 / § 7874 framework is in an unusual equilibrium — rarely triggered since 2016, but structurally important as a deterrent and analytically complex in edge cases. The OECD Pillar Two global minimum tax (**15% minimum rate**, implemented in 40+ jurisdictions starting 2024) has further changed the economics by imposing a top-up tax in formerly attractive low-tax jurisdictions like Ireland, eroding one of the primary inversion destinations and raising questions about whether § 7874 needs updating for the post-Pillar-Two environment. Treasury's § 7874 regulations were largely finalized in 2020; open questions involve partnership-based structures and certain non-ordinary-course transactions. For legislative tracking, the **BUILD Act** and similar bills to lower the § 7874 80% threshold have been introduced in multiple Congresses but not enacted. The **Tax Policy Center** (**taxpolicycenter.org**), **Tax Foundation** (**taxfoundation.org**), and **Joint Committee on Taxation** staff studies and Blue Books at **jct.gov/publications** are the authoritative sources for § 4985 and § 7874 legislative history and policy analysis.

## State Variations

§ 4985 is a federal excise tax; states do not have an equivalent. However, state income taxes on stock compensation — when it eventually vests or is exercised — are unaffected by the federal excise. California, New York, and other high-income-tax states continue to tax the income from stock compensation regardless of whether the 15% federal excise has been paid. The 15% excise is not deductible for federal income tax purposes under § 275.

## Pending Legislation

- **Corporate inversion reform**: The OECD Pillar Two global minimum tax (15% minimum corporate rate, in effect in 140+ countries) significantly changes the economics of corporate inversions by making low-tax jurisdictions less attractive. As Pillar Two implementation matures, the anti-inversion rules may need to be updated to address new structures.
- **BUILD Act / Stop Corporate Inversions**: Legislation to further tighten § 7874 rules has been introduced in multiple Congresses; these bills generally seek to lower the 80% threshold that triggers full inversion treatment, or to disregard certain transaction structures entirely.

## Recent Developments

- **Inversion activity collapsed after 2016 and hasn't revived**: The combination of the April 2016 Treasury emergency regulations, TCJA's reduction of the U.S. corporate rate to 21%, and the GILTI minimum tax on foreign income effectively ended large-scale corporate inversions. § 4985 is rarely triggered today — most major cross-border M&A is structured carefully to keep former U.S. shareholders below the § 7874 60% threshold, or to structure deals as genuine foreign acquisitions rather than inversions. The high-profile deals that defined the 2014–2016 inversion wave (Medtronic-Covidien, AbbVie-Shire, Pfizer-Allergan cancelled) have not been replicated at scale.
- **OECD Pillar Two (global minimum tax) changed inversion economics further**: The OECD/G20 Pillar Two framework, implemented by the EU, UK, Australia, Japan, and approximately 40 other countries starting in 2024, imposes a 15% global minimum corporate tax on multinationals with revenues above €750 million. For U.S. companies, Pillar Two creates an ironic reversal: Ireland's 12.5% rate (historically attractive for inversions) is now supplemented by a Pillar Two top-up tax to 15% in many cases, reducing the residual advantage. As Pillar Two implementation matures, some of the remaining anti-inversion rules may need to be updated to account for the changed international tax environment.
- **Treasury § 7874 regulations remain an active area**: The Treasury has continued to issue guidance on the § 7874 anti-inversion rules, particularly regarding the treatment of "cash boxes" (foreign acquiring corporations with large pools of foreign cash that inflate the non-U.S. shareholder percentage) and certain partnership-based inversion structures. The 2016 temporary regulations were largely finalized in 2020. Tax practitioners must stay current on IRS guidance as multinationals consider cross-border restructurings short of formal inversions — particularly IP migration and holding company structures.
- **§ 4985 interaction with expanded § 162(m) remains relevant for inverted companies**: For the small number of companies that complete transactions triggering § 4985 exposure, the interaction with § 162(m)'s $1 million deduction limitation for covered executive compensation requires careful modeling. Compensation paid as the excise tax under § 4985 is not deductible by the corporation (§ 275), and the underlying stock compensation may also be subject to § 162(m) non-deductibility. Multi-layered executive compensation tax analysis is essential in any qualifying inversion transaction.

## Sources
- [Corporate Inversion Excise Tax — Expatriated Entities (§ 4985) on PolicyRisk](https://policyrisk.com/wiki/expatriated-entities-inversion-excise)

## Related
- [international tax gilti fdii](https://policyrisk.com/wiki/international-tax-gilti-fdii)
- [fatca foreign account reporting](https://policyrisk.com/wiki/fatca-foreign-account-reporting)
- [c corporation federal tax](https://policyrisk.com/wiki/c-corporation-federal-tax)
- [golden parachute 280g](https://policyrisk.com/wiki/golden-parachute-280g)

Source: PRIA, https://policyrisk.com/wiki/expatriated-entities-inversion-excise (as of 2026-11-01).